(lp0
S'Market: The Stephens Inc. AR Continues to Hold Position in ZIOPHARM Oncology ... Petro Global News 24 - Jan 26, 2017 Several other large investors also recently bought and sold shares of ZIOP. Principal Financial Group Inc. raised its stake in ZIOPHARM Oncology by 2.0% in the third quarter. Principal Financial Group Inc. now owns 21,806 shares of the biotechnology&nbsp;...'
p1
aS'Earnings Clues on PDC Energy, Inc. , ZIOPHARM Oncology, Inc. (ZIOP ... StockNewsJournal - 20 hours ago ZIOPHARM Oncology, Inc. , at its latest closing price of $7.33, it has a price-to-book ratio of 0.00, compared to an industry average at 10.80.Thrivent Financial for Lutherans Continues to Hold Stake in ZIOPHARM Oncology ... - Sports PerspectivesLooking Mainly At Fundamentals: ZIOPHARM Oncology, Inc. , Navient ... - USA Commerce Daily'
p2
aS'ZIOPHARM Oncology Inc  Moves Lower on Volume Spike for April 14 Equities.com - Apr 14, 2017 ZIOPHARM Oncology Inc  traded on unusually high volume on Apr. 14, as the stock lost 1.48% to close at $7.33. On the day, ZIOPHARM Oncology Inc saw 2.33 million shares trade hands on 9,543 trades. Considering that the stock averages only a&nbsp;...ZIOPHARM Oncology  Earns Daily News Sentiment Score of 0.25 - The Cerbat GemZIOPHARM Oncology, Inc.  Stock Update &amp; Valuation Review - Business Review'
p3
aS"ZIOPHARM Oncology Inc  Moves Lower on Volume Spike for April 13 Equities.com - Apr 13, 2017 ZIOPHARM Oncology Inc  traded on unusually high volume on Apr. 13, as the stock lost 1.48% to close at $7.33. On the day, ZIOPHARM Oncology Inc saw 2.32 million shares trade hands on 9,539 trades. Considering that the stock averages only a&nbsp;...ZIOPHARM Oncology, Inc. surged in the Previous Trading Session with the Change ... - Free ObserverWhat Analyst suggest about Stock? ZIOPHARM Oncology, Inc.'s  - Is stories"
p4
aS'ZIOPHARM Oncology Inc  Soars 9.9% on April 12 Equities.com - Apr 12, 2017 ZIOPHARM Oncology Inc  had a good day on the market for Wednesday April 12 as shares jumped 9.9% to close at $7.44. About 3.79 million shares traded hands on 14,183 trades for the day, compared with an average daily volume of 1.47 million&nbsp;...Stock for Your Case: ZIOPHARM Oncology, Inc.  - StandardOracle'
p5
aS"Company Update : ZIOPHARM Oncology Inc. Announces 4Q:16 Financial ... Smarter Analyst - Feb 16, 2017 ZIOPHARM Oncology Inc.  announced financial results for the fourth quarter ended December 31, 2016, and provided an update on the Company's recent activities."
p6
aS'ZIOPHARM Oncology, Inc.  And The Naked Truth Exposed In Its Technicals NY Stock News - Apr 13, 2017 ZIOPHARM Oncology, Inc.  has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.'
p7
aS'Griffin Lifts Price Target on ZIOPHARM Oncology Inc.  Ahead of ... Smarter Analyst - Feb 9, 2017 Griffin analyst Keith Markey sees golden prospects ahead for ZIOPHARM Oncology Inc. , particularly taking into account the seven clinical trials the firm has forthcoming on the table for this year; trials which the analyst commends as&nbsp;...'
p8
aS'ZIOPHARM Oncology Inc.  Shares Rose 10% Following Positive Meeting with ... Smarter Analyst - Mar 27, 2017 ZIOPHARM Oncology Inc.  shareholders woke up to a nice 10% pop in the value of their shares, after the drug maker announced the receipt of positive guidance from an End-of-Phase 2 meeting with the U.S.ZIOPHARM Oncology Inc  Soars 13.78% on March 27 - Equities.comChecking the Overall Picture for ZIOPHARM Oncology, Inc.  - StockNewsJournal'
p9
aS'Griffin Commends ZIOPHARM Oncology Inc.  Following Suspension Of Breast ... Smarter Analyst - Feb 27, 2017 ZIOPHARM Oncology Inc.  has indicating the firm will be shifting its R&amp;D pipeline, centering its IL-12 gene therapy program on glioblastoma following the suspension of future development of its breast cancer therapy program.'
p10
a.